<?xml version="1.0" encoding="UTF-8"?>
<EmailTemplate xmlns="http://soap.sforce.com/2006/04/metadata">
    <available>true</available>
    <description>Overall Courtesy FPR Completed Email</description>
    <encodingKey>ISO-8859-1</encodingKey>
    <name>Overall Courtesy FPR Completed Email</name>
    <style>none</style>
    <subject>IMPORTANT: Courtesy FPR {!PubReviewTeam__c.Publication__c} Has Been Reviewed and is Now Complete</subject>
    <textOnly>Do not reply to this email message.

Courtesy FPR {!PubReviewTeam__c.PubIDLink__c}has been reviewed and is now complete. Reviewer comments can be accessed using the link below.

Contact the FPR coordinator, {!PubReviewTeam__c.AssignedFPRCFF__c}, If you have questions or need support.

LEGAL AND COMPLIANCE DISCLAIMER: If an electronic copy of the publication is submitted to external reviewers or meeting/journal, please ensure the following:
•	There are no embedded data (links to data or confidential information). Pay special attention to tables and/or figures generated from underlying Excel spreadsheets that may contain Amgen Confidential Information.
•	Remove proprietary information that may appear in the Speaker Notes of oral presentations.
•	Set the security on all documents. Note that PDFs are editable unless secured.
•	Be aware that Amgen may not wish to disclose AMG numbers for early-phase products.
•	Remove “Amgen Confidential” from versions of documents to be publicly disseminated.

Please note that the FPR process does not fulfill the Amgen requirement for Final Review by All Authors. Refer to the Amgen Publications SOP (014321-7.0) for policy and standard practices across all groups that collaborate with outside authors.

{!PubReviewTeam__c.PubIDLink__c}

Thank you,
FPR System</textOnly>
    <type>custom</type>
</EmailTemplate>
